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A B S T R A C T   
Pleural effusion is a relatively rare feature of IgG4-related disease (IgG4-RD). Here, we report a case of a 72-year- 
old woman who presented with pleural effusion. Although the pleural adenosine deaminase level was increased, 
surgical biopsy of the pleura and left inguinal lymph node indicated that the effusion was due to IgG4-RD. Active 
surveillance was initiated because serum IgG4 and pleural effusion naturally decreased and then completely 
disappeared. The patient has shown no recurrence for >4 years. This case suggests that pleural biopsy can be 
used to distinguish IgG4-RD from tuberculosis; moreover, some cases with pleural effusion could improve 
without treatment.   
1. Introduction 
Immunoglobulin G4-related disease (IgG4-RD) is a chronic disease 
that manifests with inflammation and fibrosis of involved tissue. It is 
characterized by the presence of IgG4-positive plasma cells and lym-
phocytic infiltration into tissues. IgG4-RD was first reported in 2001 [1], 
and the Ministry of Health, Labor and Welfare, Japan (MHLW Japan) 
reported the diagnostic criteria for IgG4-RD in 2011 [2]. However, 
IgG4-RD shows various clinical features that are not included in these 
criteria. 
Here, we describe a unique case of IgG4-RD accompanied by uni-
lateral pleural effusion that exhibited spontaneous remission. Pleural 
effusion is a relatively rare manifestation of IgG4-RD; in this case, an 
elevated level of adenosine deaminase (ADA) was also observed in the 
pleural effusion. We performed surgical pleural biopsy to distinguish the 
disease from tuberculous pleurisy, and the pathological analysis 
supported a diagnosis of IgG4-RD. The serum IgG4 level and pleural 
effusion gradually decreased without any treatment, and remission has 
been maintained for >4 years. Additionally, we have reviewed the 
literature from 2001 to 2018 in the MEDLINE database based on a search 
for IgG4-RD with pleural effusion and its clinical presentations.1 
2. Case report 
A 72-year-old woman was referred to our hospital for evaluation of 
left pleural effusion of unknown origin. She had a history of bronchial 
asthma with noteworthy findings in her family history, including auto-
immune diseases and tuberculosis. She reported never smoking or 
drinking. She had general fatigue for 6 months and had reported left 
dominant pleural effusion to her previous doctor; however, the cause of 
pleural effusion was unclear. 
On physical examination, her temperature was 37.0 C, blood 
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pressure was 149/92 mmHg, and pulse was 110 beats per minute. 
Percutaneous arterial oxygen saturation (SpO2) was 93% on room air. 
Her right axillary lymph node was palpable. Lung sounds were dimin-
ished in the left lung, without the presence of piping rale. Laboratory 
analysis showed that the erythrocyte sedimentation rate was elevated to 
118 mm/h and serum IgG level was 5310 mg/dL, including IgG4 > 1500 
mg/dL. Both rheumatoid factor and antinuclear antibody were negative. 
Analyses of tumor markers and the interferon-gamma release test 
revealed negative findings (Table 1). Chest radiograph showed left 
pleural effusion (Fig. 1a). Neck to pelvis computed tomography (CT) 
revealed swelling of the mediastinal and inguinal lymph nodes as well as 
left pleural effusion with local pleural thickness (Fig. 1b). Fluorodeox-
yglucose (FDG) positron emission tomography imaging showed accu-
mulation of FDG in the mediastinal lymph node, left inguinal lymph 
node, and left pleura (Fig. 1c). 
Thoracentesis showed lymphocyte-dominant exudative pleural 
effusion with a high level of ADA. Culture and polymerase chain reac-
tion analyses of pleural effusion were performed to assess the presence 
of tuberculosis and nontuberculous mycobacteria. Both tests were 
negative (Table 2). 
We suspected the possibility of IgG4-RD based on clinical findings 
and the elevated level of serum IgG4. However, we needed to confirm 
the pathological diagnosis and exclude tuberculous pleurisy with 
elevated ADA in unilateral pleural effusion. Therefore, we performed 
surgical biopsies of the pleura and left inguinal lymph node (Fig. 2). 
Histological analysis of the biopsies revealed dense lymphocyte and 
plasmacyte infiltration accompanied by fibrosis. Immunohistochemical 
analysis showed that a large number of IgG4 cells (50 cells or more per 
high-power field) were found in the pleural membrane and inguinal 
lymph node; the IgG4/IgG cell ratio exceeded 40%, which met the 
diagnostic criteria for IgG4-RD [3]. Thus, we diagnosed the patient with 
definite IgG4-RD with pleural effusion and inguinal lymph node 
Table 1 
Laboratory data on admission.  
Peripheral blood  Blood biochemistry  
WBC 2800 /μL TP 9.8 g/dL 
Ne 52.5 % Alb 2.6 g/dL 
Ly 28.0 % T-Bil 0.45 mg/dL 
Mo 7.5 % AST 23 U/L 
Eo 2.0 % ALT 20 U/L 
Ba 5.5 % ALP 99 U/L 
RBC 379 *104/μL γ-GTP 11 U/L 
Hb 11.3 g/dL ChE 157 IU/L 
Ht 33.9 % LDH 166 U/L 
Plt 262 *103/μL Na 135 mmol/L    
K 3.7 mmol/L 
Coagulation  Cl 103 mmol/L 
PT 10.2 sec Ca 8.3 mg/dL 
APTT 30.5 sec BUN 8.9 mg/dL 
PT-INR 0.99  Cre 0.41 mg/dL 
FDP <2.5 μg/mL UA 4.5 mg/dL 
D-dimer <0.5 μg/mL T-cho 125 mg/dL    
Ferritin 169.3 ng/mL 
Serology   KL-6 140 IU/L 
CRP 0.09 mg/dL fT3 2.45 pg/mL 
ESR 118 mm/hr fT4 1.02 pg/mL 
RF 10.1 IU/mL TSH 2.96 μIU/mL 
IgG 5309.7 mg/dL ACE 11.5 IU/L 
IgG4 >1500 mg/dL    
IgA 89.7 mg/dL Tumor marker  
IgM 22.4 mg/dL CEA 0.55 ng/mL 
IgE 2152 IU/mL CYFRA 1.7 ng/mL 
C3 64.3 mg/dL ProGRP 28 pg/mL 
C4 20.3 mg/dL    
CH50 37 IU/mL Urinalysis   
ANA negative  pH 6.5  
SS-A negative  Protein –  
SS-B negative  Glucose –  
IL-6 1.04 pg/mL Occult blood –  
s-IL2R 1513 IU/mL Sediment negative  
BNP 36 pg/mL    
QFT negative     
Abbreviations: WBC, white blood cells; Ne, neutrophils; Ly, lymphocytes; Mo, 
monocytes; Eo, eosinophils; Ba, basophils; RBC, red blood cells; Hb, hemoglobin; 
Ht, hematocrit; Plt, platelets; CRP, C-reactive protein; ESR, erythrocyte sedi-
mentation rate; RF, rheumatoid factor; IgG, immunoglobulin G; IgG4, immu-
noglobulin G4; IgA, immunoglobulin A; IgM, immunoglobulin M; IgE, 
immunoglobulin E; C3, complement component 3; C4, complement component 
4; CH50, total complement activity; ANA, antinuclear antibodies; SS-A, anti- 
Sjogren’s-syndrome-related antigen A; SS-B, anti-Sjogren’s-syndrome-related 
antigen B; IL-6, interleukin-6; s-IL2R, soluble interleukin-2 receptor; BNP, B-type 
natriuretic peptide; QFT, QuantiFERON; TP, Treponema pallidium; Alb, albumin; 
T-Bil, total bilirubin; AST, aspartate transaminase; ALT, alanine transaminase; 
ALP, alkaline phosphatase; γ-GTP, gamma-glutamyl transpeptidase; ChE, 
cholinesterase; LDH, lactate dehydrogenase; Na, sodium; K, potassium; Cl, 
chloride; Ca, calcium; BUN, blood urea nitrogen; Cre, creatinine; UA, uric acid; 
T-cho, total cholesterol; KL-6, Krebs von den Lungen-6; fT3, free triiodothyro-
nine; fT4, thyroxine; TSH, thyroid-stimulating hormone; ACE, angiotensin- 
converting enzyme; CEA, carcinoembryonic antigen; CYFRA, cytokeratin 19 
Fragment; ProGRP, pro-gastrin-releasing peptide. 
Fig. 1. Chest X-ray (a), computed tomography (CT) (b), and fluorodeox-
yglucose positron emission tomography/CT (FDG-PET/CT) imaging (c) on 
admission. Chest X-ray showed left pleural effusion. Neck to pelvis CT imaging 
revealed swelling of the mediastinal and inguinal lymph nodes, as well as left 
pleural effusion with local pleural thickness (yellow arrows). FDG-PET/CT 
imaging showed FDG accumulation in the mediastinal lymph node, left 
inguinal lymph node, and left pleura (yellow arrows). . (For interpretation of 
the references to colour in this figure legend, the reader is referred to the Web 
version of this article.) 
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swelling. 
We then considered initiation of corticosteroid therapy; however, 
pleural effusion decreased without intervention, and dyspnea improved 
during the active surveillance period (Fig. 3a). The serum IgG/IgG4 
levels gradually decreased (Fig. 3b) and the swelling of the mediastinum 
and inguinal lymph nodes also subsided (Fig. 3c). Therefore, we 
continued surveillance of the patient without administration of any 
drug; there has been neither obvious regrowth nor development of 
malignant disease for >4 years. 
3. Discussion 
We have herein reported long-term remission with active surveil-
lance of IgG4-RD with pleural effusion. To clarify the characteristics of 
IgG4-RD with pleural effusion, we conducted a review of the English- 
language literature by a MEDLINE search using the following key-
words: “IgG4-related disease” AND “pleural effusion” OR “pleuritis.” 
Cases with unclear clinical data or unmatched clinical symptoms (e.g., 
without serum IgG4 or pleural effusion) were excluded. We ultimately 
Table 2 
Thoracocentesis findings.  
Biochemistry   Cell counts  
TP 6.6 g/dL  5483 /μL 
Alb 1.6 g/dL mono 99 % 
Glucose 76 mg/dL poly 1 % 
LDH 103 U/L    
ADA 80.2 U/L    
CEA <0.20 ng/mL     
Microbiology test      
Smear negative     
Culture negative     
PCR      
Mycobacterium tuberculosis negative     
Mycobacterium avium negative     
Mycobacterium intracellulare negative     
Abbreviations: TP, total protein; Alb, albumin; LDH, lactate dehydrogenase; 
ADA, adenosine deaminase; CEA, carcinoembryonic antigen; PCR, polymerase 
chain reaction. 
Fig. 2. Histological findings of pleura and inguinal 
lymph node biopsy specimens. (a): Histological 
analysis of the pleura revealed dense lymphocyte 
and plasmacyte infiltration, accompanied by fibrosis 
[hematoxylin and eosin (H&E) staining, magnifica-
tion: 10 (upper left), 400 (upper right)]. Immu-
nohistochemical analysis showed a large number of 
IgG4 cells (50 cells or more per high-power field) in 
the pleura; the IgG4/IgG cell ratio exceeded 40% 
[immunohistochemical (IHC) staining, magnifica-
tion: 200 (IgG staining; lower left, IgG4 staining; 
lower right)]. (b): Histological analysis of the 
inguinal lymph node revealed dense lymphocyte and 
plasmacyte infiltration, accompanied by fibrosis 
[H&E staining, magnification: 10 (upper left), 
400 (upper right)]. Immunohistochemical analysis 
showed a large number of IgG4 cells (50 cells or 
more per high-power field) in the inguinal lymph 
node; the IgG4/IgG cell ratio exceeded 40% [IHC 
staining, magnification: 400 (IgG staining; lower 
left, IgG4 staining; lower right)].   
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analyzed 21 cases (including the present case) (Table 3) [4–22]. 
Review of these 21 cases revealed some recurring rare characteris-
tics. First, the possibility of IgG4-RD should be considered even if pleural 
effusion is unilateral and the ADA level is elevated. Fei et al. reported 
that, among a prospective cohort of 248 IgG4-RD cases, 87 (35.1%) had 
intrathoracic lesions; only 4 cases (4.6%) had pleural effusion [23]. 
Thus, IgG4-RD manifesting with pleural effusion seems relatively rare. 
Additionally, most cases of IgG4-RD (15/20 cases) exhibited bilateral 
pleural effusion; however, some cases, including our case, demonstrate 
unilateral pleural effusion (Table 3). 
As a differential diagnosis, tuberculous pleurisy must be considered, 
because both diseases could manifest with unilateral pleural effusion 
accompanied by elevated ADA levels [24–26]. The sensitivity of direct 
examination of pleural fluid by Ziehl-Neelsen staining or culture was 
low in previous reports [24]. Krenke et al. reported that ADA activity in 
pleural fluid is a highly sensitive and specific marker of tuberculous 
pleurisy (sensitivity: 100%, specificity: 93.9%; cut-off value of 40.4 U/L) 
[27]. However, patients with IgG4-RD can sometimes exhibit elevation 
of ADA levels in pleural effusion [22]. Our review showed that ADA 
elevation was present in 2/5 cases (at the cut-off value of 40.4 U/L) 
(Table 3). The underlying mechanism associated with elevated ADA 
levels in pleural effusion of IgG4-RD is still unknown. In IgG4-RD, type 2 
helper T (Th2) cells and regulatory T cells overexpress cytokines, 
including interleukins (IL-4, 5, 10, and 13), promoting eosinophilia and 
leading to increased serum IgG4 and IgE levels [28]. On the other hand, 
ADA is predominantly produced by monocytes or macrophages via the 
activation of cell-mediated immunity [29]. Therefore, it is suggested 
that the interaction of T cells and B cells may induce the activation of 
cell-mediated immunity in IgG4-RD, which could lead to the elevation of 
ADA levels in pleural effusion [22]. Consequently, it is sometimes 
difficult to distinguish tuberculous pleurisy and IgG4-RD in patients 
with unilateral pleural effusion and elevated ADA levels. In some cases, 
IgG4-RD and Mycobacterium tuberculosis infection were concurrently 
diagnosed [30–33]. In these reports, it is hypothesized that the Th2 
activation induced by latent or reactivated tuberculosis results in 
IgG4-RD. To distinguish tuberculous pleurisy and IgG4-RD accurately, 
the pathological features and the culture results of the pleural biopsy 
specimen are important. In this case, the histological feature without 
granulomatous lesion and the negative results of the M. tuberculosis 
culture and PCR analysis also supported the diagnosis of IgG4-RD. 
The second rare characteristic identified in our review was that some 
patients with IgG4-RD accompanied by pleural effusion showed 
improvement of symptoms and pleural effusion without treatment. 
Brito-Zeron et al. revealed that 56 (27.2%) of 206 systemic IgG4-RD 
patients did not undergo therapy, and only 20 patients showed remis-
sion [34]. There are few descriptions of cases manifesting as pleuritis or 
pleural effusion. In our review of such cases, none improved without 
corticosteroid therapy, with the exception of our case; some cases were 
refractory to corticosteroid therapy. Our case is the first report of 
improvement in IgG4-RD with pleural effusion solely via long-term 
active surveillance. However, there are currently no clear criteria for 
treatment decisions (i.e., whether patients should receive immunosup-
pressive therapy or active surveillance). Therefore, clinical symptoms, 
radiographs, CT images, and serum IgG/IgG4 levels must be carefully 
observed to determine the treatment strategy. 
The pathogenesis of IgG4-RD remains to be clarified, but an excessive 
immune response seems to play some role in the progression [35]. A 
recent study suggested that IgG4-RD may be driven by a specific antigen 
[36]. If such pathogenesis were applicable in our patient, it may explain 
the spontaneous remission of IgG4-related pleuritis. Antigen exposure 
may be temporary, or immune tolerance might be induced for the 
antigen. 
In conclusion, we have described a case of IgG4-RD with unilateral 
pleural effusion accompanied by elevated ADA levels, which improved 
without treatment. Unilateral pleural effusion with elevated ADA levels 
is a relatively rare clinical manifestation, and such cases should be 
distinguished from tuberculous pleurisy by surgical biopsy of the pleura. 
In addition, some patients with IgG4-RD can show improvement of 
symptoms without treatment. Prognostic factors—those that support 
good response to either corticosteroid therapy or active surveillance-
—are unknown. Further cases are needed to evaluate such factors in 
order to provide adequate treatment strategies for patients with IgG4- 
RD in the future. 
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Fig. 3. (a): Clinical course after the patient was referred to our hospital. Serum 
IgG and IgG4 decreased without treatment. (b): Chest X-ray appearance at the 
time the patient was referred to our hospital (left), and after 4 years of obser-
vation (right). (c): Computed tomography imaging at the time the patient was 
referred to our hospital (i, ii), and after 4 years of observation (iii, iv). Medi-
astinal lymph nodes (i, iii) and left inguinal lymph nodes (ii, iv) are shown as 
yellow arrows. 
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2008 Miyake K 65 M 1194 Mikulicz’s disease, lymph node swelling L NR PSL 30 Improved 
2009 Rossi G 63 F 420 Pericardial effusion, lymph node swelling, 
Autoimmune pancreatitis, Hashimoto’s 
disease 
BL NR Steroid NR Improved 
2011 Yamamoto H 78 M 483 – BL 34.1–46.7 Surveillance – No change 
2012 Sekiguchi H 29 F 136 – BL NR PSL 40 Improved 
2013 Kojima M 57 M 970 – BL NR Steroid NR Improved 
2014 Choi JH 48 M 248 – BL NR PSL 0.6 mg/ 
kg 
Improved 
2014 Ishida A 74 F 740 – BL Normal PSL 25 Improved 
2014 Ishida M 71 F 684 Pericardial effusion R NR PSL 40 Improved 
2014 Kato E 69 M 277 – BL 39.9 PSL 30 Improved 
2015 Goag EK 16 M 1650 – BL 10.7–15 PSL  AZA  surgical 
obliteration 
1mg/kg Improved 
2015 Ohkubo H 68 F 307 Uterus BL NR PSL 0.6 mg/ 
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Improved 
2015 Waheed W 74 M 217 Neuromyopathy R NR PSL 40 Improved 
2016 Gonzalez- 
Moreno J 
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2016 Gonzalez- 
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